Health Care & Life Sciences » Biotechnology | Iris Biotechnologies Inc.

Iris Biotechnologies Inc.

Iris Biotechnologies Inc.
Stock Exchange Other OTC
Market Cap
$1.32 M
Shares Outstanding
21.37 M
Public Float
6.36 M


5201 Great America Parkway
Santa Clara California 95054
United States
Employees -
Updated 07/08/2019
Iris Biotechnologies, Inc. is a life sciences company focused on health care. It offers the best approach to the treatment of cancer and other diseases through actionable integration of molecular profiling in the clinical decision-making process. The Iris Nano-Biochip product pipeline include CancerChip, PrenatalChip, Integrated Blood Test, IVF applications, NeuroChip, MetabolicChip, CardioChip, and Chips for veterinary, agricultural, environmental, and other applications.


View All

Simon S. M. Chin
Chairman, President, CEO, CFO & Secretary
Grace Osborne
Director, VP-Business Development & HR